China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 21.93
-0.39 (-1.75%)
At close: Feb 13, 2026
SHE:300294 Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 466.15M CNY in the quarter ending September 30, 2025, with 33.43% growth. This brings the company's revenue in the last twelve months to 1.96B, up 15.06% year-over-year. In the year 2024, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 1.73B, down -34.58%.
Revenue (ttm)
1.96B
Revenue Growth
+15.06%
P/S Ratio
5.63
Revenue / Employee
1.01M
Employees
1,938
Market Cap
11.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.73B | -917.08M | -34.58% |
| Dec 31, 2023 | 2.65B | -106.72M | -3.87% |
| Dec 31, 2022 | 2.76B | 108.17M | 4.08% |
| Dec 31, 2021 | 2.65B | 137.49M | 5.47% |
| Dec 31, 2020 | 2.51B | -395.73M | -13.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition